Evogene and CIRAD expand their cotton collaboration
Advertisement
Evogene Ltd. and CIRAD, a French scientific organization, announced the expansion of their multi-year collaboration signed in 2004. The goal of the new project is to introduce Evogene's candidate gene, EVO133, into cotton and to validate it's improvement for drought tolerance.
EVO133 is Evogene's candidate gene for yield, and yield stability under drought, heat and salinity conditions. EVO133 has been tested in three seasons of field trials in processing tomato varieties and has demonstrated its potential to increase yield under normal conditions, reduce yield penalty under drought conditions as well as under salinity and heat stresses. The validation of EVO133 is also advancing in other target crops under other collaborations, which have been announced publicly, namely in Corn with Biogemma and Soybean with Mertec.
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease
No gene is an island - Gene’s neighborhood can influence whether and how the activity of a gene changes
Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells - New approach could dramatically improve the success rate of immune-cell therapies
American_Medical_Marijuana_Association
Sartorius closes acquisition of selected assets of Danaher Life Sciences - Broadens portfolio for the development and production of biotech medicines
First synthetic tissue model developed in which blood vessels can grow